TREACE MEDICAL CONCEPTS (TMCI) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
TREACE MEDICAL CONCEPTS insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $1.5M and 0 sold $0 of TMCI stock on the open market.
Get emailed when insiders cluster-buy stocks like TMCI
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TMCI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $247K | 3 | — | 0 |
| Q2 2026 | $1.2M | 11 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 TREACE MEDICAL CONCEPTS, INC. insider reported open-market purchases totaling $1.5M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, John T. Treace (CEO) has the highest Insider Score at 97.
TMCI stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Earnings release
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 24SEC | John T. TreaceCEO | Buy | 39,9447,388,383 held (+1%) | $4.44 | $177K | -11.0% | 97 |
| Aug 24SEC | John T. TreaceCEO | Buy | 11,0007,404,383 held (+0%) | $4.34 | $48K | -9.0% | 97 |
| Aug 24SEC | John T. TreaceCEO | Buy | 5,0007,393,383 held (+0%) | $4.35 | $22K | -9.2% | 97 |
| Jun 12SEC | John T. TreaceCEO | Buy | 14,7157,338,548 held (+0%) | $4.02 | $59K | -1.7% | 97 |
| Jun 12SEC | John T. TreaceCEO | Buy | 9,8917,348,439 held (+0%) | $4.04 | $40K | -2.2% | 97 |
| Jun 11SEC | John T. TreaceCEO | Buy | 29,4307,353,263 held (+0%) | $4.02 | $118K | -1.7% | 97 |
| Jun 11SEC | John T. TreaceCEO | Buy | 22,8877,376,150 held (+0%) | $4.04 | $92K | -2.2% | 97 |
| Jun 1SEC | John T. TreaceCEO | Buy | 50,0007,323,833 held (+1%) | $3.56 | $178K | +11.0% | 97 |
| May 28SEC | John T. TreaceCEO | Buy | 61,2027,273,833 held (+1%) | $3.02 | $185K | +30.8% | 97 |
| May 28SEC | John T. TreaceCEO | Buy | 49,8107,212,631 held (+1%) | $2.87 | $143K | +37.6% | 97 |
| May 28SEC | John T. TreaceCEO | Buy | 4,5087,162,821 held (+0%) | $2.79 | $13K | +41.6% | 97 |
| May 14SEC | John T. TreaceCEO | Buy | 61,7507,158,313 held (+1%) | $2.62 | $162K | +50.8% | 97 |
| May 14SEC | John T. TreaceCEO | Buy | 49,0137,096,563 held (+1%) | $2.46 | $121K | +60.6% | 97 |
| May 14SEC | John T. TreaceCEO | Buy | 43,0007,047,550 held (+1%) | $2.17 | $93K | +82.0% | 97 |
Insiders at TREACE MEDICAL CONCEPTS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| John T. TreaceCEO | $1.5M | — | Aug 24, 2026 | 97 |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
TMCI stock: common questions
Are TREACE MEDICAL CONCEPTS, INC. insiders buying TMCI stock?
In the past 12 months, 1 insiders reported open-market purchases of TMCI worth $1.5M. The latest was CEO John T. Treace bought $177K of TMCI at $4.44.
Are TREACE MEDICAL CONCEPTS, INC. insiders selling TMCI stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TMCI's 52-week range?
Over the past year TMCI has traded between $1.20 and $6.95. It last closed at $3.95 on Oct 9, 2026.